Editorial Policies

Focus and Scope

Aim and Scope: “Medical Hypothesis, Discovery & Innovation in Ophthalmology” is an international quarterly peer-reviewed journal published since January 2012, publishes basic and clinical science studies and other relevant manuscripts related to the visual science. Furthermore, we publish evidence-based ideas and hypotheses in the realm of ophthalmology, optometry and visual sciences. We look for discoveries, minimal invasive surgeries, new modalities of treatment, innovative instruments and any manuscript that contains creativity and ideas in visual sciences to publish them for maximum visibility. Manuscripts are accepted that have not been and will not be published elsewhere, without any ethical problem and malpractice in their content. This journal is currently indexed at: Chemical Abstracts, PubMed Central, Hinari World Health Organization (WHO), ProQuest and PubsHub. The Journal is the member and ICMJE and the Journal editor is the member of WAME at present in view of publication and ethical principles. In case of any ethical malpractice (fraud, plagiarism, etc) we approach to guidelines of WAMEICMJE and all principleas presented at this webpage.

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Section A, Publication: All submissions undergo a peer-review process performed by at least two reviewers. These reviewers are expert in their fields. The final decision could be as accepted, minor or major revision or fast rejection. 1. Language, originality, reliability, statistical validity and relevance are important factors for reviewers. 2. There is no warranty to accept the manuscript if authors are encouraged to revise and resubmit the manuscript. 3. It is of noteworthy that rejected manuscripts would not be re-reviewed unless extremely rare circumstances. 4. Acceptance considers legal provisions including plagiarism and copyright infringement.

Section B, Authors' Responsibilities: All authors should declare that their paper is their own original research. However, they must warranty reality and authenticity of their data. Also they must declare that their paper has not been published elsewhere before, or even submitted and under review in another journal. However, they shall participate in the peer review process. The corresponding author takes primary responsibility for communication with the journal office during all steps and follows the ethical principles in publication. The corresponding author should respond to editorial office and should cooperate with any requests from the journal after publication. Our Journal does not allow adding/deleting authors or changing the orders of authors following the final acceptance. All authors must follow the rules for authorship mentioned above and declare their financial interest. Acknowledgment should be clearly declared in all submissions. All conflict of interests must be mentioned exactly the same as all resources that helped performing their research work. Conflict of intrests include (but are not limited to):

  • Research grants from funding agencies (The research funder and the grant number are required),
  • Financial support for educational programs,
  • Employment or consultation,
  • Position on advisory board or board of directors or other types of management relationships,
  • Financial relationships, for example, receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future,
  • Intellectual property rights (e.g. patents, copyrights and royalties from such rights),
  • Holdings of spouse and/or children that may have financial interest in the work

An informed written consent should be obtained from all participants or their legal parties. The name of the review board that approved the work must be mentioned in the manuscript. All animal research should respect to Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines (https://www.nc3rs.org.uk/arrive-guidelines). The authors should follow Declaration of Helsinki in medical research involving human subjects. Authors should guarantee the integrity of reported data. Ethical issues should be completely observed by the authors. All named authors must meet the ICMJE criteria for authorship, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published. Finally, the corresponding author signs the copyright agreement on behalf of co-authors. The ICMJE recommends that authorship is based on the followings: "1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2. Drafting the work or revising it critically for important intellectual content; AND 3. Final approval of the version to be published; AND 4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work is appropriately investigated and resolved.” The authors must consider all ethical regulations of ICMJE as well as these ethical regulations: 1. Declaration of interests: funding that helped you must be mentioned. 2. Registering clinical trials: there are international and national trusted registries to register clinical trials. 3. Respecting confidentiality: patients’ information should be kept secret and anonymous. Also, protecting patient or animal rights under investigation is of great importance. The welfare of animals used for research must be respected. As mentioned, authors should obtain ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment. Authors should proceed to register the trials registries & bear a clinical trial registration number. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT guidline. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from a different journal that is not open access.

Section C, Peer review/Responsibility of the Reviewers: All submissions undergo a peer-review process. All data in the manuscript regarding subjects must be kept secret by the reviewers. Author(s) may present list names of potential reviewers when submitting a publication, however selection remains the editor decision. No personal criticism of the author should be involved in the review of the manuscript. Knowing the author should not affect the process of reviewing and decision making. Relevant previously published articles must be identified by the reviewer if not cited in the references. Also, any similarity regarding data or method with other previously published manuscripts must be reported to the Editor-in-Chief. However, if there is any conflict of interest between the reviewer and the authors, the manuscript must be edited by another reviewer.

Section D, Editorial Responsibilities: It is the editor right to reject or accept a submitted manuscript. Editors must pay attention to readers and journal scope and also the authors’ needs when editing the manuscript. Also, a corrigendum must be written if there are any errors in the manuscript. Funding support of the manuscript should be obviously clarified for the editors. Decision making of the manuscript by the author is done based on the paper novelty, originality and scope of the journal. It is rare to change the decision of a manuscript after final decision of editor unless there is a very serious reason. Concordance with ethics guidelines must be checked by the editors. If there is doubt regarding any misconduct in a published or unpublished paper, the editors must ensure to fix the issue appropriately. But, a manuscript should not be rejected due to doubt, unless there is a reasonable proof. Any conflicts of interest should be avoided between authors, personnel, editors, and reviewers.

Section E, Ethics and Malpractice Statement: We follow the rules and regulations released by the “International Committee of Medical Journal Editors (ICMJE)” including all aspects regarding the conduct of research, how to report a research, style, edit, and finally publishing the manuscript. Hence, it is strongly recommended if author(s) read these recommendations prior to submission (http://www.icmje.org). If there is any plagiarism or misconduct detected in data or publication, the editors have the right to inform the author or affiliated institute and act based on the COPE (Committee on Publication Ethics) guidelines (https://publicationethics.org/core-practices). Conflict of interest happens when there is a personal or financial association between any part in publication process such as authors, reviewers, or editors of journals which could lead to any disturbance in performing their roles. Therefore, based on the ICMJE rules, any conflict of interest should be reported in a special format for consideration by the editors. ICMJE rules must be obeyed by all the editorial members, reviewers and authors. The Journal is the member of WAME and ICMJE at present in view of publication and ethical principles. The editorial board will incessantly work towards observing publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical problem with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and etc. When the journal faces suspected cases of research and publication misconduct, the resolving process will be followed by guidelines provided by the "Committee on Publication Ethics (COPE)".

Section F, Open Access: This is an open-access Journal. All manuscripts distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistributing the material just in noncommercial usages, provided the original work is properly cited. We received no government, educational, charitable or any other kind of funding. Therefore, we are compelled to operate our work on the basis of the article processing fees that collect from authors. The submission of a manuscript and peer-review processes are free of charge. Article processing fee applies only to manuscripts accepted for publication. If a paper is accepted for publication, the authors need to pay a publication processing fee equal to 990 EURO prior to PROOF. We do offer a discounted rate for invited authors as well as for manuscripts from developing countries. “Publication Fee Assistance” is intended for authors who demonstrate financial need. Our journal does not disclose information about an applicant's application status for fee assistance to journal editors or reviewers. Publication decisions are based solely on editorial criteria. Processing fee covers the cost of open access manuscript, journal production, web hosting, CMS, database, online repository, archiving, XML conversion, reference formatting, unlimited number of color figures, and English editing. To find out the latest discounted rate please contact editorial office at: info@meptic.com.

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

MEHDI Ophthalmology Journal

This is an interdisciplinary journal devoted to the publication of studies interrelating visual sciences. Manuscripts will be considered for publication if that the results reported are based on original and novel research and hypothesis.



ISSN: 2322-3219